Locally Advanced Penile Carcinoma: Classic Emasculation Or Testis-Sparing Surgery? ______Lúcio Flávio Gonzaga-Silva, George R

Total Page:16

File Type:pdf, Size:1020Kb

Locally Advanced Penile Carcinoma: Classic Emasculation Or Testis-Sparing Surgery? ______Lúcio Flávio Gonzaga-Silva, George R Vol. 38 (6): 750-759, November - December, 2012 ORIGINAL ARTICLE Locally advanced penile carcinoma: classic emasculation or testis-sparing surgery? ______________________________________________________________________________________________ Lúcio Flávio Gonzaga-Silva, George R. M. Lima, José M. Tavares, Vladmir O. Pinheiro, George A. Magalhães, Manoel E. Tomas, Cleto D. Nogueira, Marcos V. A. Lima Ceará Cancer Hospital (LFGS, JMT, VOP, GAM, MET, CDN, MVAL) and Federal University of Ceará (LFGS, GRML), Ceará. Brazil ABSTRACT ARTICLE INFO _________________________________________________________ ___________________ Purpose: The study evaluates the clinical and pathological fi ndings of 16 patients with Key words: locally advanced penile carcinoma (PC) submitted to emasculation, and discusses ques- Orchiectomy; Penile tions related to the usefulness of bilateral orchiectomy. Neoplasms; Carcinoma, Materials and Methods: Between 1999 and 2010, 172 patients with PC were treated. Squamous Cell; Penis Sixteen (9%) underwent emasculation. Data were retrieved from the institution’s da- tabase including age, ethnicity, date of surgery, residential setting, level of schooling, Int Braz J Urol. 2012; 38: 750-9 time to diagnosis, type of reconstruction, complications, tumor stage and grade, vas- __________________ cular and perineural invasion along with invasion of corpus cavernosum, corpus spon- giosum, testicles, scrotum and urethra. Submitted for publication: Results: A total of 16 patients (average: 63.1 years) with locally advanced PC were February 12, 2012 included. All were illiterate or semiliterate rural dwellers and 87% were white. The time __________________ to diagnosis was 8-12 months. The mean follow-up time was 31.9 months (1-119). By the time of the last follow-up, only seven patients (43.75%) were alive. Tumors were Accepted after revision: pT4 (n = 6), pT3 (n = 8), pT2 (n = 2), Grade I (n = 5) and Grade II (n = 11). The histopa- August 14, 2012 thological examination revealed invasion of the urethra (n = 13), scrotum (n = 5) and testicles (n = 1). The surgical margin was positive in one patient. Six patients (37.5%) had vascular invasion and 11 (68.7%) had perineural invasion. Currently, only one of the former is alive. Conclusions: The fi nding of focal microscopic testicular infi ltration in only one of 32 testicles, even in the presence of clinically apparent scrotal invasion, suggests that emasculation without bilateral orchiectomy is a safe treatment option for patients with locally advanced PC. INTRODUCTION than 1/100,000 in the US and Europe to more than 4/100,000 in Uganda and Brazil (4). Penile carcinoma (PC), a potentially fatal Brazil has one of the highest incidences of malignancy, is rare in developed countries (1). penile cancer in the world. The disease represents In the United States, for instance, it accounts for 2.1% of male neoplasms in the country, reaching only 0.4% of all male malignancies (2), while in 5.7% in the Northeast (5) where the human deve- less developed regions, especially in Asia, Africa, lopment index is very low. Not surprisingly, the and South America, the fi gure may be as high as region accounts for more than half (53.02%) of 10% (3). The incidence typically ranges from less the cases registered in Brazil. In comparison, whe- 750 IBJU | LOCALLY ADVANCED PENILE CARCINOMA: EMASCULATION OR TESTIS-SPARING SURGERY? reas 2 or 3 new cases of PC are observed every tion), scrotectomy and bilateral orchiectomy (14). month at the Ceará Cancer Hospital in Fortaleza The present study evaluates the clinical (Northeastern Brazil) (6), a British practicing uro- and pathological fi ndings of 16 patients with lo- logist may not see more than one new case every cally advanced penile squamous cell carcinoma other year. submitted to emasculation and discusses ques- The causes of penile cancer are not always tions related to surgical technique, patient follow- clear, but major risk factors include poor penis -up and the usefulness of bilateral orchiectomy. hygiene, phimosis, smegma retention, smoking and sexually transmitted diseases (7,8). In a recent MATERIALS AND METHODS Brazilian multicenter study, the practice of sex with animals was also identifi ed as a risk factor Between 1999 and 2010, 172 patients for this malignancy (9). with penile invasive squamous cell carcinoma Penile carcinoma metastasizes stepwise were submitted to surgical treatment at the Ceará via the lymphatic system: from the inguinal nodes Cancer Hospital in Fortaleza, Brazil. Of these, 16 to the pelvic nodes to the distant nodes (10). The advanced cases (9.3%) underwent emasculation presence and extent of lymph node metastases are (Table-1). the most important predictors of survival (4). His- Complete preoperative, operative and pos- tological grade and vascular and perineural inva- toperative patient data were retrieved from the sion have been correlated with poor prognosis and institution’s prospective database and from a re- unfavorable outcomes (11). view of the respective medical records. The infor- Surgical management of malignant PC de- mation included patients’ age, ethnicity, date of pends on the grade and stage of the disease (12). surgery, residential setting (rural or urban), level The National Institute for Clinical Excellence (U.K) of schooling, time from appearance of fi rst lesion recommends managing PC at centers with a ca- to defi nitive diagnosis, type of reconstruction, du- tchment area of 4 million. Each center receives ration of follow-up and date of last follow-up vi- approximately 25 new cases annually. Advanced sit. The median follow-up time was calculated as cases of PC are referred to a supra-regional center the median observation time among patients and for multidisciplinary curative and palliative treat- the overall survival time was estimated using the ment, including reconstructive surgery (13). Kaplan-Meier method. At our service, PC patients with proximal Specimens were obtained from all patients corpus cavernosum invasion and scrotal skin ero- and evaluated by a single pathologist with regard sion are routinely referred to emasculation, in- to tumor stage and grade, inguinal lymph node cluding total penectomy (complete penis amputa- status, vascular and perineural invasion, invasion Table 1 - Cases of penile squamous cell carcinoma submitted to surgical treatment at the Ceará Cancer Hospital between 1999 and 2009. Surgical technique Cases (n) Percent (%) Wide local excision or circumcision 5 3% Partial penectomy 125 73% Total penectomy 26 15% Emasculation 16 9% Total 172 100% 751 IBJU | LOCALLY ADVANCED PENILE CARCINOMA: EMASCULATION OR TESTIS-SPARING SURGERY? of corpus cavernosum, corpus spongiosum, testi- Pelvic lymphadenectomy was performed in four cles, scrotum and urethra. patients. The pathological nodal status was defi ned All 16 patients were submitted to emas- as: N0 = no evidence of lymph node metastasis; N1 culation, including total penectomy, scrotectomy = metastasis in a single inguinal lymph node; N2 = and bilateral orchiectomy. The technique consis- metastasis in multiple or bilateral superfi cial lymph ted of an elliptical abdominoscrotal incision with nodes and N3 = unilateral or bilateral metastasis large skin margin and partial preservation of the in deep or pelvic lymph nodes. The excised tumors posterior surface of the scrotum. With the corpus were clinically and pathologically staged according cavernosum and corpus spongiosum exposed, the to the guidelines of the International Union Against urethra was dissected and mobilized. The corpus Cancer (2002 TNM UICC) (17). cavernosum was disinserted from the ischial tu- The study was previously approved by the berosity followed by en bloc removal of the penis, Institutional Ethics Committee and the principles of scrotum and testes. The urethra was tunneled wi- the Helsinki Declaration were followed in all study thout angulation, spatulated and externalized in procedures. the perineum, as described by Campbell (15). The surgical wound was closed with a RESULTS scrotal fl ap in 9 patients. Seven patients required two forms of reconstruction: 1) a vertical rectus The 16 patients undergoing emasculation abdominis myocutaneous fl ap was made through were aged 63.1 years on the average (range: 40- a midline abdominal incision, preserving the pos- 78). Fourteen patients (87%) were white and two terior layer of aponeurotic and inferior epigastric (13%) were black. All were illiterate or semiliterate vessels. The skin grafts were rotated to achieve rural dwellers (Table-2). The time from the appe- complete wound closure; 2) an eliptical incision arance of the fi rst penile lesion to the defi nitive was made in the medial aspect of the thigh, star- diagnosis was 8-12 months. ting 10 cm below the ischium, in order to preserve Radical bilateral inguinal lymphadenec- the medial circumfl ex femoral arteries, followed tomy was performed in 11 patients 3-4 weeks af- by wound closure with a gracilis myocutaneous ter emasculation. Due to extensive loco-regional fl ap. Both reconstruction techniques were perfor- disease, in fi ve patients treatment was limited to med with the assistance of a plastic surgery team. surgical debulking for palliative and hygiene pur- Four patients who had previously under- poses, followed by reconstruction (Figure-1). gone partial penectomy required emasculation The pathological nodal status of the 11 pa- due to tumor recurrence (at 6,2,9 and 13 months, tients undergoing radical inguinal lymphadenec- respectively). The previous
Recommended publications
  • Phalloplasty and Urethral
    plastol na og A y Golpanian et al., Anaplastology 2016, 5:2 Anaplastology DOI: 10.4172/2161-1173.1000159 ISSN: 2161-1173 Review Article Open Access Phalloplasty and Urethral (Re)construction: A Chronological Timeline Samuel Golpanian, Kenneth A Guler, Ling Tao, Priscila G Sanchez, Klara Sputova and Christopher J Salgado* Division of Plastic Surgery, DeWitt Daughtry Family, University of Miami, Miami, FL, USA Abstract Since the first penile reconstruction in 1936, various techniques of phalloplasty and urethroplasty have been developed. These advancements have paralleled those in the field of plastic and reconstructive surgery and offer a complex patient population the opportunity of restoration of cosmetic and psychosexual function. The continuous evolution of these methods has resulted in constant improvement of the surgical techniques in use today. Here, we aim to describe a historical overview of phalloplasty and urethral (re)construction. Keywords: Phalloplasty; Urethroplasty; Reconstruction; Transgen- gender reassignment over the next 40 years. Various fasciocutaneous der; Surgery and extended pedicle island flaps were also developed during this time. Nonetheless, they continued to have suboptimal functional and Introduction aesthetic results due to their significant limitations in sensory recovery Phalloplasty is a complex surgical task. Successful creation or primarily [10,13,14]. restoration of the penis must meet certain cosmetic and functional Throughout the 1970’s other innovations were introduced in the field thresholds. The ideal neophallus should be sensate, hairless, and similar of penile reconstruction. In 1971, Kaplan et al. [15] developed a method in color to the surrounding skin. It should have an inconspicuous scar, that provided sensation to the neophallus.
    [Show full text]
  • Part 2-Organ-Sparing Procedures in Testicular and Penile Tumors
    International Urology and Nephrology (2019) 51:1699–1708 https://doi.org/10.1007/s11255-019-02182-6 UROLOGY - REVIEW Organ‑sparing procedures in GU cancer: part 2‑organ‑sparing procedures in testicular and penile tumors Mohamed H. Kamel1,3 · Mahmoud I. Khalil1,3 · Ehab Eltahawy1,3 · Rodney Davis1 · Nabil K. Bissada2 Received: 1 May 2019 / Accepted: 23 May 2019 / Published online: 2 July 2019 © Springer Nature B.V. 2019 Abstract Purpose Organ-sparing surgery (OSS) is recommended in selected patients with testicular tumors and penile cancer (PC). The functional and psychological impacts of organ excision for these genital tumors are profound. In this review, we sum- marize the indications, techniques and outcomes of OSS for these two tumors. Methods PubMed® was searched for relevant articles up to December 2018. For Testicular sparing surgery (TSS) search, keywords used were; testicular tumors alone and in combination with “testicular sparing surgery”, “partial orchiectomy” and outcomes. For penile conserving surgery (PCS), keywords used were: penile cancer alone and in combination with “penile conserving surgery”, “partial penectomy” and outcomes. Because of the low quality of available evidence, a narrative rather that systematic review has been performed. Results Indications of TSS are tumors ≤ 2 cm in solitary testis or bilateral tumors and no rete testis invasion. Prerequisites include normal testosterone and luteinizing hormone levels and patient compliance with follow-up. Indications for PCS are distal penile lesions with clinical stage ≤ T1. Adequate penile stump (3 cm) is required after surgery to maintain forward urine stream. Frozen section helps to reduce the risk of recurrence. Local recurrence after PCS is not associated with reduced survival and can be managed with another PCS in selected patients.
    [Show full text]
  • EAU Guidelines on Penile Cancer 2001
    European Association of Urology GUIDELINES ON PENILE CANCER* F. Algaba, S. Horenblas, G. Pizzocaro, E. Solsona, T. Windahl TABLE OF CONTENTS PAGE 1. Background 3 2. Classification 3 2.1 Pathology 3 2.2 References 4 3. Risk factors 5 3.1 References 5 4. Diagnosis 6 4.1 Primary lesion 6 4.2 Regional nodes 6 4.3 Distant metastases 7 4.4 Guidelines on the diagnosis of penile cancer 8 4.5 References 8 5. Treatment 9 5.1 Primary lesion 9 5.2 Regional nodes 9 5.3 Guidelines on the treatment of penile carcinoma 11 5.4 Integrated therapy 11 5.5 Distant metastases 11 5.6 Quality life 11 5.7 Technical aspects 12 5.8 Chemotherapy 12 5.9 References 14 6. Follow-up 15 6.1 Why follow-up? 15 6.2 How to follow-up 16 6.3 When to follow-up 16 6.4 Guidelines for follow-up in penile cancer 17 6.5 References 18 7. Abbreviations used in the text 19 2 1. BACKGROUND Penile carcinoma is an uncommon malignant disease with an incidence ranging from 0.1 to 7.9 per 100,000 males. In Europe, the incidence is 0.1–0.9 and in the US, 0.7–0.9 per 100,000 (1). In some areas, such as Asia, Africa and South America, penile carcinoma accounts for as many as 10–20% of male cancers. Phimosis and chronic irritation processes related to poor hygiene are commonly associated with this tumour, whereas neonatal circumcision gives protection against the disease.
    [Show full text]
  • From Circumcision Injury to Penile Amputation
    Hindawi Publishing Corporation BioMed Research International Volume 2014, Article ID 375285, 6 pages http://dx.doi.org/10.1155/2014/375285 Review Article Traumatic Penile Injury: From Circumcision Injury to Penile Amputation Jae Heon Kim,1 Jae Young Park,2 and Yun Seob Song1 1 Department of Urology, Soonchunyang University Hospital, College of Medicine, Soonchunhyang University, Seoul, Republic of Korea 2 Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea Correspondence should be addressed to Jae Young Park; [email protected] and Yun Seob Song; [email protected] Received 24 April 2014; Revised 16 August 2014; Accepted 16 August 2014; Published 28 August 2014 Academic Editor: Ralf Herwig Copyright © 2014 Jae Heon Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The treatment of external genitalia trauma is diverse according to the nature of trauma and injured anatomic site. The classification of trauma is important to establish a strategy of treatment; however, to date there has been less effort to make a classification for trauma of external genitalia. The classification of external trauma in male could be established by the nature of injury mechanism or anatomic site: accidental versus self-mutilation injury and penis versus penis plus scrotum or perineum. Accidental injury covers large portion of external genitalia trauma because of high prevalence and severity of this disease. The aim of this study is to summarize the mechanism and treatment of the traumatic injury of penis.
    [Show full text]
  • Gender Affirming Surgery and Related Procedures State(S): LOB(S): Idaho Montana Oregon Washington Other: Commercial Medicare Medicaid
    Gender Affirming Surgery and Related Procedures State(s): LOB(s): Idaho Montana Oregon Washington Other: Commercial Medicare Medicaid Enterprise Policy BACKGROUND The American Psychiatric Association’s Diagnostic and Statistical Manual, 5th Edition (DSM 5) defines criterion A of Gender Dysphoria as “a marked incongruence between one’s experience/expressed gender and assigned gender.” These individuals must meet additional criteria which include persistence over time and clinically significant distress or impairment in social, occupational or other important areas of functioning. Benefits must be verified by reviewing the plan’s contract or plan document (PD). Some PacificSource benefit plans do not include coverage of gender affirming surgery, procedures or other related treatment. Groups may elect to customize these benefits; therefore, benefit determinations are based on specific contract language. CRITERIA The member should be placed into case management by Health Services as a way to help the member understand their benefits and required criteria related to gender affirming surgery and treatment, and to assist her/him to navigate the system and promote an optimal outcome. Covered Services and Exclusions – Commercial, Medicaid 1. The following are considered medically necessary gender affirming surgeries. a. Core surgical procedures considered medically necessary for females transitioning to males include: hysterectomy, vaginectomy, salpingo-oophorectomy, metoidioplasty, phalloplasty, urethroplasty, scrotoplasty, perineal electrolysis, and placement of testicular implant and mastectomy including nipple reconstruction. b. Core surgical procedures considered medically necessary for males transitioning to females include: penectomy, orchiectomy, vaginoplasty, clitoroplasty, perineal electrolysis, labiaplasty, and mammoplasty when 12 continuous months of hormonal (estrogen) therapy has failed to result in breast tissue growth of Tanner Stage 5 on the puberty scale or there is any contraindication to, or intolerance of, or patient refusal of hormone therapy.
    [Show full text]
  • Delineation of Privileges Urology Privileges Provider Name
    Delineation Of Privileges Urology Privileges Provider Name: Privilege Requested Deferred Approved UROLOGY PRIVILEGES Criteria - New Applicants:: Board Certification or qualified for certification by the American Board of Urology. Criteria - Current Staff Members Only: Successful completion of an ACGME or AOA approved training program; OR demonstrated acceptable practice in the privileges being requested for a minimum of five (5) years. Proctoring Requirements: A minimum of eight (8) cases, in accordance with the Medical Staff Proctoring Protocol. GENERAL PRIVILEGES: Admit ___ ___ ___ Consultation Only Privileges ___ ___ ___ Surgical Assist Only ___ ___ ___ Local block anesthesia ___ ___ ___ Regional block anesthesia ___ ___ ___ Sedation analgesia ___ ___ ___ Criteria: Requires successful completion of the Sedation Assessment test. Additional criteria effective April 1, 2015: a) Evidence of current ACLS and/or PALS certification from the American Heart Association; AND b) Evidence of completion of an Airway Management Course a) Adult Sedation ___ ___ ___ b) Pediatric Sedation (17 years and under) ___ ___ ___ CATEGORY 1 - UROLOGY PRIVILEGES ___ ___ ___ Includes the management and coordination of care, treatment and services, including: medical history and physical evaluations, consultations and prescribing medication in accordance with DEA certificate. Urethral, bladder catheterization ___ ___ ___ Suprapubic, bladder aspiration ___ ___ ___ Page 1 Printed on Wednesday, December 10, 2014 Delineation Of Privileges Urology Privileges Provider
    [Show full text]
  • A Comprehensive Review of a Rare Subclass of Mucosal Melanoma with Emphasis on Differential Diagnosis and Therapeutic Approaches
    cancers Review Urological Melanoma: A Comprehensive Review of a Rare Subclass of Mucosal Melanoma with Emphasis on Differential Diagnosis and Therapeutic Approaches Gerardo Cazzato 1,*,† , Anna Colagrande 1,†, Antonietta Cimmino 1, Concetta Caporusso 1, Pragnell Mary Victoria Candance 1, Senia Maria Rosaria Trabucco 1, Marcello Zingarelli 2, Alfonso Lorusso 2, Maricla Marrone 3 , Alessandra Stellacci 3 , Francesca Arezzo 4, Andrea Marzullo 1, Gabriella Serio 1, Angela Filoni 5, Domenico Bonamonte 5, Paolo Romita 5, Caterina Foti 5, Teresa Lettini 1 , Vera Loizzi 4, Gennaro Cormio 4 , Leonardo Resta 1 , Roberta Rossi 1,‡ and Giuseppe Ingravallo 1,‡ 1 Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari “Aldo Moro”, 70124 Bari, Italy; [email protected] (A.C.); [email protected] (A.C.); [email protected] (C.C.); [email protected] (P.M.V.C.); [email protected] (S.M.R.T.); [email protected] (A.M.); [email protected] (G.S.); [email protected] (T.L.); [email protected] (L.R.); [email protected] (R.R.); [email protected] (G.I.) 2 Section of Urology, Deparment of Emergency and Organ Transplantation (DETO), University of Bari “Aldo Moro”, 70124 Bari, Italy; [email protected] (M.Z.); [email protected] (A.L.) 3 Section of Legal Medicine, Interdisciplinary Department of Medicine, Bari Policlinico Hospital, Citation: Cazzato, G.; Colagrande, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124 Bari, Italy; [email protected] (M.M.); A.; Cimmino, A.; Caporusso, C.; [email protected] (A.S.) Candance, P.M.V.; Trabucco, S.M.R.; 4 Section of Ginecology and Obstetrics, Department of Biomedical Sciences and Human Oncology, Zingarelli, M.; Lorusso, A.; Marrone, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124 Bari, Italy; [email protected] (F.A.); M.; Stellacci, A.; et al.
    [Show full text]
  • Delayed Multiple Port Sites Metastases After Laparoscopic Radical Prostatectomy
    CASE REPORT Delayed Multiple Port Sites Metastases After Laparoscopic Radical Prostatectomy Brusabhanu Nayak, MS, MCH, Prem Nath Dogra, MS, MCH, Vaibhav Saxena, MS, MCH, Ashis Saini, MS, MCH Department of Urology, All India Institute of Medical Sciences, New Delhi, India (all authors). ABSTRACT Introduction: Laparoscopic port site metastases are recurrent nodular lesions developing locally in the abdominal wall within the scar tissue of one or more trocar sites. We are reporting an extremely rare case of delayed multiple port site metastases 3 years after laparoscopic radical prostatectomy. In this case, 3 port site metastases appeared 3 years after laparoscopic radical prostatectomy. Case Description: A 65-year-old man was evaluated for lower urinary tract symptoms and found to have raised serum prostate-specific antigen of 9.06 ng/mL. Transrectal ultrasonography-guided biopsy of the prostate revealed an adeno- carcinoma of the prostate (Gleason score 3 ϩ 4 ϭ 7), with 5 of 12 cores positive for tumor. Contrast-enhanced computed tomography showed localized disease with no involvement of seminal vesicle or lymph nodes. The bone scan was normal. He underwent laparoscopic radical prostatectomy for localized carcinoma of the prostate. He developed 3 port site metastases 3 years after surgery. In view of multiple port site metastatic disease, bilateral orchiectomy was done. The patient is doing well after 1 year of follow-up. Conclusion: We report an occurrence of delayed multiple port site metastases after laparoscopic radical prostatectomy. The 3 sites of metastases in our case included the extraction site, the most active instrument site, and the drain placement site.
    [Show full text]
  • Gender Dysphoria Treatment – Commercial Medical Policy
    UnitedHealthcare® Commercial Medical Policy Gender Dysphoria Treatment Policy Number: 2021T0580J Effective Date: April 1, 2021 Instructions for Use Table of Contents Page Related Commercial Policies Coverage Rationale ....................................................................... 1 • Blepharoplasty, Blepharoptosis and Brow Ptosis Documentation Requirements ...................................................... 3 Repair Definitions ...................................................................................... 4 • Botulinum Toxins A and B Applicable Codes .......................................................................... 5 • Cosmetic and Reconstructive Procedures Description of Services ................................................................. 9 • Gonadotropin Releasing Hormone Analogs Benefit Considerations .................................................................. 9 Clinical Evidence ......................................................................... 10 • Habilitative Services and Outpatient Rehabilitation U.S. Food and Drug Administration ........................................... 15 Therapy References ................................................................................... 15 • Panniculectomy and Body Contouring Procedures Policy History/Revision Information ........................................... 16 • Rhinoplasty and Other Nasal Surgeries Instructions for Use ..................................................................... 17 Community Plan Policy • Gender Dysphoria
    [Show full text]
  • Gender Dysphoria Treatment – Community Plan Medical Policy
    UnitedHealthcare® Community Plan Medical Policy Gender Dysphoria Treatment Policy Number: CS145.I Effective Date: March 1, 2021 Instructions for Use Table of Contents Page Related Community Plan Policies Application ..................................................................................... 1 • Blepharoplasty, Blepharoptosis, and Brow Ptosis Coverage Rationale ....................................................................... 1 Repair Definitions ...................................................................................... 3 • Botulinum Toxins A and B Applicable Codes .......................................................................... 4 • Cosmetic and Reconstructive Procedures Description of Services ................................................................. 8 • Gonadotropin Releasing Hormone Analogs Benefit Considerations .................................................................. 9 Clinical Evidence ........................................................................... 9 • Panniculectomy and Body Contouring Procedures U.S. Food and Drug Administration ........................................... 14 • Rhinoplasty and Other Nasal Surgeries References ................................................................................... 14 • Speech Language Pathology Services Policy History/Revision Information ........................................... 16 Commercial Policy Instructions for Use ..................................................................... 16 • Gender Dysphoria Treatment
    [Show full text]
  • Robotic Surgery for Male Infertility
    Robotic Surgery for Male Infertility Annie Darves-Bornoz, MD, Evan Panken, BS, Robert E. Brannigan, MD, Joshua A. Halpern, MD, MS* KEYWORDS Robotic surgical procedures Infertility Male Vasovasostomy Varicocele KEY POINTS Robotic-assisted approaches to male infertility microsurgery have potential practical benefits including reduction of tremor, 3-dimensional visualization, and decreased need for skilled surgical assistance. Several small, retrospective studies have described robotic-assisted vasectomy reversal with com- parable clinical outcomes to the traditional microsurgical approach. Few studies have described application of the robot to varicocelectomy, testicular sperm extrac- tion, and spermatic cord denervation. The use of robotic-assistance for male infertility procedures is evolving, and adoption has been limited. Rigorous studies are needed to evaluate outcomes and cost-effectiveness. INTRODUCTION with intraperitoneal and pelvic surgery. On the other hand, many of the theoretic and practical ad- Up to 15% of couples have infertility, with approx- 1,2 vantages offered by the robotic approach are imately 50% of cases involving a male factor. A highly transferrable to surgery for male infertility: substantial proportion of men with subfertility have surgically treatable and even reversible etiologies, High quality, 3-dimensional visualization is such as a varicocele or vasal obstruction. The essential for any microsurgical procedure. introduction of the operating microscope revolu- Improved surgeon ergonomics are always desir- tionized the field of male infertility, dramatically able, particularly given the surgeon morbidity improving visualization of small, complex associated with microsurgery.3 anatomic structures. The technical precision Filtering of physiologic tremor can improve pre- afforded has improved operative outcomes across cision during technically demanding micro- the board.
    [Show full text]
  • 2020 Coding and Payment Guide
    MEN’S HEALTH 2020 Coding and Payment Guide This coding reference guide is intended to illustrate the common coding and payment groups for male prosthetic urology and related procedures. This guide is limited to coding and payment for male prosthetic urology procedures performed in the hospital outpatient site-of-service, ambulatory surgery center (ASC) site-of-service and procedures performed by physicians. The rates listed below are reflective of 2020 Medicare national average reimbursement rates and will vary due to geographic adjustment and other factors. These rates are subject to change without notice. 2020 Coding and Payment Guide Effective January 1, 2020 Total Hospital Code Description APC ASC Physicians RVUs Outpatient (Facility) Urinary Sling Procedures Sling operation for correction of male urinary incontinence 53440 5376 $8,067.93 $6.546.11 $784.59 21.74 (e.g., fascia or synthetic) Removal or revision of sling for male incontinence 53442 5375 $4,231.62 $1,976.27 $816.35 22.62 (e.g., fascia or synthetic) Penile Procedures 54110 Excision of penile plaque (Peyronie’s Disease) 5374 $3,018.54 $1,376.97 $650.33 18.02 Excision of penile plaque (Peyronie’s Disease); with graft up 54111 5375 $4,231.62 $1,976.27 $834.03 23.11 to 5 cm in length 54112 Excision of penile plaque (Peyronie’s Disease); with graft > 5 cm in length 5376 $8,067.93 $3,995.65 $976.95 27.07 54360 Plastic operation on penis to correct angulation 5374 $3,018.54 $1,376.97 $751.39 20.82 54400 Insertion of penile prosthesis; non-inflatable (semi-rigid) 5377 $17,573.96
    [Show full text]